Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1235 |
|
| Actual shortage: | 52 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1147 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
12 (23%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-BACLOFEN | 10MG | TABLET | Resolved | 2017-04-04 | 2017-07-24 | 5457 |
| PMS-DIGOXIN | 0.125MG | TABLET | Resolved | 2017-04-04 | 2017-12-21 | 5439 |
| PMS-AMLODIPINE | 2.5MG | TABLET | Resolved | 2017-03-31 | 2019-11-14 | 4987 |
| PMS-VALPROIC ACID E.C. | 500MG | CAPSULE (ENTERIC-COATED) | Resolved | 2017-03-24 | 2017-12-19 | 4291 |
| PMS-TRAMADOL-ACET | 37.5MG 325MG | TABLET | Resolved | 2017-03-24 | 2017-12-19 | 4288 |
| PMS-TRAMADOL-ACET | 37.5MG 325MG | TABLET | Resolved | 2017-03-24 | 2017-12-19 | 4284 |
| TELMISARTAN | 80MG | TABLET | Resolved | 2017-03-24 | 2017-12-19 | 4281 |
| PMS-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-24 | 2020-06-10 | 4278 |
| PMS-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-24 | 2018-06-29 | 4274 |
| PMS-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-03-24 | 2020-06-10 | 4271 |
| PMS-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-24 | 2020-06-10 | 4268 |
| PMS-PAROXETINE | 10MG | TABLET | Resolved | 2017-03-24 | 2018-05-05 | 4265 |
| PMS-OXYCODONE | 5MG | TABLET | Resolved | 2017-03-24 | 2017-05-18 | 4262 |
| PMS-OMEPRAZOLE DR | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-03-24 | 2020-06-09 | 4259 |
| PMS-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-24 | 2020-06-09 | 4255 |
| PMS-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-24 | 2020-06-09 | 4252 |
| PMS-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-24 | 2020-06-09 | 4249 |
| PMS-LORAZEPAM | 1MG | TABLET | Resolved | 2017-03-24 | 2017-12-18 | 4246 |
| PMS-LORAZEPAM | 1MG | TABLET | Resolved | 2017-03-24 | 2017-12-18 | 4243 |
| PMS-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-24 | 2017-12-18 | 4240 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6094 |
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-05-03 | 6088 |
| PMS-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6081 |
| PMS-OXALIPLATIN | 5MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-08 | 6078 |
| PMS-OXALIPLATIN | 5MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-08 | 6075 |
| PMS-OXALIPLATIN | 5MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-08 | 6072 |
| PMS-LISINOPRIL | 5MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6069 |
| PMS-LISINOPRIL | 20MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6066 |
| PMS-LISINOPRIL | 20MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6063 |
| PMS-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6060 |
| PMS-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6057 |
| PMS-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6054 |
| PMS-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6051 |
| PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6047 |
| PMS-ENALAPRIL | 4MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6044 |
| PMS-ENALAPRIL | 16MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6041 |
| PMS-ASA EC | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2017-04-07 | 2017-04-07 | 6038 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6035 |
| AC&C TABLETS | 375MG 8MG 15MG | TABLET | Discontinued | 2017-04-07 | 2017-04-07 | 6031 |
| PMS-DIAZEPAM | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 5002 |